SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001171843-22-005878
Filing Date
2022-08-31
Accepted
2022-08-31 16:32:29
Documents
7
Effectiveness Date
2022-08-31

Document Format Files

Seq Description Document Type Size
1 FORM S-8 fs8_082922.htm S-8 31223
2 EXHIBIT 5.1 exh_51.htm EX-5.1 6320
3 EXHIBIT 23.1 exh_231.htm EX-23.1 2438
4 EXHIBIT 99.1 exh_991.htm EX-99.1 93128
5 CALCULATION OF FILING FEE TABLES exh_107.htm EX-FILING FEES 10393
6 GRAPHIC gibson_logo.jpg GRAPHIC 2427
7 GRAPHIC gibson2_logo.jpg GRAPHIC 3683
  Complete submission text file 0001171843-22-005878.txt   153237
Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-267193 | Film No.: 221218332
SIC: 2836 Biological Products, (No Diagnostic Substances)